as 02-10-2025 2:33pm EST
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
Founded: | 2018 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 773.7M | IPO Year: | 2019 |
Target Price: | $31.43 | AVG Volume (30 days): | 3.9M |
Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.01 | EPS Growth: | N/A |
52 Week Low/High: | $5.99 - $16.63 | Next Earning Date: | 02-27-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | ETNB | Director10% Owner | Jan 30 '25 | Buy | $8.75 | 5,714,285 | $49,999,993.75 | 19,554,319 | |
Le-Nguyen Quoc | ETNB | See Remarks | Jan 15 '25 | Sell | $6.49 | 10,963 | $71,149.87 | 271,833 | |
PALEKAR ROHAN | ETNB | Chief Executive Officer | Dec 6 '24 | Buy | $7.89 | 5,000 | $39,450.00 | 471,236 | |
McWherter Charles | ETNB | Director | Dec 5 '24 | Buy | $8.00 | 10,000 | $80,000.00 | 10,000 | |
PALEKAR ROHAN | ETNB | Chief Executive Officer | Nov 22 '24 | Buy | $8.35 | 10,000 | $83,500.00 | 471,236 |
ETNB Breaking Stock News: Dive into ETNB Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
MT Newswires
8 days ago
GlobeNewswire
8 days ago
GlobeNewswire
13 days ago
Motley Fool
14 days ago
GlobeNewswire
15 days ago
Investor's Business Daily
15 days ago
Argus Research
18 days ago
The information presented on this page, "ETNB 89bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.